2022
DOI: 10.3390/ijms23158418
|View full text |Cite
|
Sign up to set email alerts
|

Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery

Abstract: Multiple sclerosis (MS) is a neuroinflammatory and neurodegenerative disease with unknown etiology that can be characterized by the presence of demyelinated lesions. Prevailing treatment protocols in MS rely on the modulation of the inflammatory process but do not impact disease progression. Remyelination is an essential factor for both axonal survival and functional neurological recovery but is often insufficient. The extracellular matrix protein fibronectin contributes to the inhibitory environment created i… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
9
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 10 publications
(9 citation statements)
references
References 394 publications
0
9
0
Order By: Relevance
“…In addition, there was a considerable upregulation ( p < 0.05) of the fibronectin and PDGF genes. Fibronectin and PDGF are essential in improving wound repair and inducing tissue regeneration [ 50 ].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, there was a considerable upregulation ( p < 0.05) of the fibronectin and PDGF genes. Fibronectin and PDGF are essential in improving wound repair and inducing tissue regeneration [ 50 ].…”
Section: Discussionmentioning
confidence: 99%
“…Several genes that increased their expression in the hippocampus and partially in the cortex of OBX mice are of particular interest. They are represented by the Ywhag gene encoding 14-3-3γ protein, which increased GSK-3β activation and promoted tau phosphorylation in Alzheimer's disease [50], Fn1 -bronectin1, which declined at the onset of remyelination of the lesion area of the CNS and is implicated in BBB breakdown [51]. All studied brain structures of OBX mice were characterized by a pronounced increase in the level of expression of the Sox9 gene, which responds to Aβ deposition [52].…”
Section: Study Of Gene Expression In the Brain Regions Of Obx Mice Re...mentioning
confidence: 99%
“…Given the consensus that inflammation drives demyelination in MS patients, most of the current therapies rely on immune-modulating strategies that either dampen the overall activity of the immune system or block the entry of peripheral immune cells into the CNS [ 4 ]. However, these therapies often fail in patients with progressive MS [ 5 ], where chronic demyelination and neuroaxonal loss are the key to irreversible neurological disability [ 6 , 7 ]. Although natural partial remyelination can be detected in a small percentage of patients post-mortem, it is neither efficient nor sufficient to halt axonal atrophy and loss [ 8 ].…”
Section: Introductionmentioning
confidence: 99%